Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cancer pain management inadequate in opioid-saturated areas

Publish date:: November 11, 2019

Key clinical point: Cancer patients may have suboptimal pain management because of concerns about opioid misuse.

Major finding: More than 60% of cancer patients in the study area never received an opioid prescription for pain control.

Study details: Longitudinal exploratory analysis of claims data for 4,324 cancer patients in southwestern Virginia.

Disclosures: The study was supported by the University of Virginia Cancer Center, Cancer Control & Population Health Division and the Virginia Tobacco Region Revitalization Commission. The authors reported having no disclaimers or conflicts of interest.

Citation:

LeBaron VT et al. J Oncol Pract. 2019 Nov. 4. doi: 10.1200/JOP.19.00149.

This Week's Must Reads

Consider potential cognitive complications prior to androgen deprivation therapy,

Diabetes raises risk of prostate cancer mortality in obese men,

Salivation inhibition fails to reduce radioiodine toxicity in prostate cancer,

Highest positive surgical margin predicts poor survival after prostatectomy,

Young minority men are underinformed about prostate cancer screening,